Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Andy Reynolds. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Andy Reynolds or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Reimagining Respiration: The Quest for Better Asthma Care

22:47
 
Share
 

Manage episode 485448794 series 2551918
Content provided by Andy Reynolds. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Andy Reynolds or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In this episode of Quality Matters, Tonya Winders, President and CEO of the Global Allergy and Airways Patient Platform (GAAPP), joins host Andy Reynolds to unpack the diagnosis and care gaps that plague asthma treatment—from delayed access to spirometry, to underuse of biologics. Tonya explains what high-quality, patient-centered asthma care requires, and what health care leaders can do to close that gap.

Tonya also discusses:

  • Why a definitive diagnosis of asthma isn’t necessarily the norm.
  • What the “three-legged stool” of asthma care looks like.
  • Why patient-centricity is essential for chronic disease management.
  • How new treatments like biologics are changing what’s possible in asthma treatment.

This podcast is a must-listen for anyone working to redesign care delivery and improve outcomes for patients with chronic respiratory illness.

Key Quote:

“We are finding in that moderate to severe category, when they are diagnosed accurately and get appropriate access to targeted treatments, about one in three go into a clinical remission, where they have no exacerbations, no symptoms, no hospital, no ER, no oral corticosteroids, no use of short acting bronchodilator.

This is something that, I have to tell you, I never dreamt would come in my career. So, it's very exciting, especially for those that have had the opportunity to access these miracle drugs—that’s the term they use, miracle drugs—that have changed their lives and given them the freedom to breathe.”

Tonya Winders

Time Stamps:

  1. (04:00) Diagnostic Delays: Spirometry and Systemic Barriers
  2. (05:44) How Age and Comorbidities Obscure Asthma
  3. (08:00) Challenges of Misdiagnosis and Access to Specialists
  4. (10:28) The Three Legs of Effective Asthma Care
  5. (18:20) NCQA’s Measurement Strategy for Asthma

Links:

NCQA White Paper: Improving Outcomes for People with Asthma

Connect with Tonya Winders

  continue reading

164 episodes

Artwork
iconShare
 
Manage episode 485448794 series 2551918
Content provided by Andy Reynolds. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Andy Reynolds or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In this episode of Quality Matters, Tonya Winders, President and CEO of the Global Allergy and Airways Patient Platform (GAAPP), joins host Andy Reynolds to unpack the diagnosis and care gaps that plague asthma treatment—from delayed access to spirometry, to underuse of biologics. Tonya explains what high-quality, patient-centered asthma care requires, and what health care leaders can do to close that gap.

Tonya also discusses:

  • Why a definitive diagnosis of asthma isn’t necessarily the norm.
  • What the “three-legged stool” of asthma care looks like.
  • Why patient-centricity is essential for chronic disease management.
  • How new treatments like biologics are changing what’s possible in asthma treatment.

This podcast is a must-listen for anyone working to redesign care delivery and improve outcomes for patients with chronic respiratory illness.

Key Quote:

“We are finding in that moderate to severe category, when they are diagnosed accurately and get appropriate access to targeted treatments, about one in three go into a clinical remission, where they have no exacerbations, no symptoms, no hospital, no ER, no oral corticosteroids, no use of short acting bronchodilator.

This is something that, I have to tell you, I never dreamt would come in my career. So, it's very exciting, especially for those that have had the opportunity to access these miracle drugs—that’s the term they use, miracle drugs—that have changed their lives and given them the freedom to breathe.”

Tonya Winders

Time Stamps:

  1. (04:00) Diagnostic Delays: Spirometry and Systemic Barriers
  2. (05:44) How Age and Comorbidities Obscure Asthma
  3. (08:00) Challenges of Misdiagnosis and Access to Specialists
  4. (10:28) The Three Legs of Effective Asthma Care
  5. (18:20) NCQA’s Measurement Strategy for Asthma

Links:

NCQA White Paper: Improving Outcomes for People with Asthma

Connect with Tonya Winders

  continue reading

164 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play